Overview
Call for Abstracts
Submission Deadline
Friday, August 28, 2026
100%
Agree the that the EGFR Resisters Research Summit will impact their current research and/or professional career
100%
Agree the information presented will improve research and/or publication/presentation skills
100%
Agree that the EGFR Resisters Research Summit can improve the scientific rigor and publication quality of their interprofessional research team
—Among prior EGFR Resisters Research Summit Participants
Eligibility
North American-based Junior Faculty and Fellows (MDs, MD/PhDs) involved in research related to EGFR-mutated lung cancer. We encourage applicants from all related disciplines (thoracic oncologists, surgeons, radiation oncologists, pathologists, palliative care) and other clinical lab-based and translational researchers to submit!
- Junior Faculty (Instructors or Assistant Professors)
- Trainee (Must be enrolled in an ACGME-accredited fellowship program or PhD postdoctoral fellowship)
- PhD Candidates (A limited number of applicants that are conducting lab-based EGFR NSCLC research will be considered)
Candidates must be based in North America and training must be completed at a North American-based institution.
All work must be unpublished original research in an area related to EGFR-mutated lung cancer. For junior candidates who do not yet have a scientific abstract to submit, we will also accept a career statement highlighting your goals and trajectory as related to this area, previously published information, journal club presentation, or other like projects representing professional development.
Abstracts to be presented at future medical meetings are eligible for submission.
Abstract Policies & Procedures
- Only one abstract submission per Young Investigator will be accepted.
- Abstracts must conform to the abstract preparation instructions. Those that do not may be rejected.
- Only original work completed by the Young Investigator will be accepted.
- All accepted abstracts will be published in an electronic program to be provided to all attendees. The publication of electronic handout materials will not preclude publication or presentation elsewhere.
Selection Process
- Expert Faculty Judges will review and score all submissions. Number of abstracts to be selected for presentation will depend on quantity and quality of abstracts received.
- Young Investigators selected for participation will present their abstracts in an 8-minute oral presentation at the meeting with 7 minutes of Q&A.
“The Research Summit provided invaluable facetime with experts in the field and an opportunity to receive feedback from patient advocates and leaders in cancer research.” —Prior EGFR Resisters Research Summit Participant
“[The Summit] helped me to significantly improve my presentation skills, as well as defend my research, and I have future plans for the research and what I learn about grant writing from great mentors.” —Prior EGFR Resisters Research Summit Participant
“The Summit provided valuable feedback on my scientific ideas and provided hands-on teaching to improve presentation skills.” —Prior EGFR Resisters Research Summit Participant
Educational Partners
Supported through an independent educational grant from AstraZeneca.